ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

Mankind Pharma Limited Complete list of announcements declared & dividend announcements by Mankind Pharma Limited MANKIND

Mankind Pharma Limited MANKIND listed on NSE and deals in

Announcements and dividends declared by Mankind Pharma Limited MANKIND

Block deals: Canada Pension Plan sells 0.5% in Nykaa for Rs 256 cr; Hema CIPEF offloads 0.46% in Mankind Pharma
Through the stake sale, Canada Pension Plan took home about Rs 256 crore. At the end of March quarter, it held 1.47% equity in the company. In separate deals, Capital group affiliate Hema CIPEF has sold 0.46% stake in Mankind Pharma for Rs 2,082 apiece, ta
Announcement as on 10 July 2024

Block Deal: Hema CIPEF likely to sell around 1% stake in Mankind Pharma
Capital Group held a 2.22% stake in the company as on March 31, 2024. In December last year, Capital Group divested a 3.14% stake in Mankind Pharma.
Announcement as on 09 July 2024

Block Deals: Mankind Pharma to see stake sale worth Rs 763 cr; Canada Pension Plan may sell 3.17% in Delhivery
Hema CIPEF is selling 37 lakh shares (0.9% of its total equity) at a discounted price of Rs 2,061 per share, 2% below the current market value. As of the end of March, Hema CIPEF, a fund mostly owned by the company's promoters, held a 2.22% stake in Hema.
Announcement as on 09 July 2024

Company Announcement

Announcement as on 27 June 2024

Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 crore
Warburg Pincus, ChrysCapital, TPG, Blackstone, EQT, Mankind Pharma, and Dr Reddy's Laboratories are competing to acquire BSV Group, a biopharma firm specializing in women's health and critical care products, indicating a trend of consolidation in the domes
Announcement as on 07 June 2024

Announcements by Mankind Pharma Limited first page | Next page | Prev page |

MANKIND Mankind Pharma Limited current price & indicator signals

Moving Averages for Mankind Pharma Limited

  • 5Day Average: 2222.74
  • 12Day Average: 2149.15
  • 20Day Average: 2118.89
  • 50Day Average: 2145.02
  • 100Day Average: 2213.97
  • 150Day Average: 2319.61
  • 200Day Average: 2351.76

MANKIND Indicators & signals

Indicator MACD (12,26,9)

2170.52, 2144.63, 8.31
Indicator MACD is in positive zone

Indicator ADX (14)

11.33, 24.62, 19.61
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MANKIND Mankind Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Fri Mar 2026 2187.00 2178.10 to 2231.70 -1.77% 0.48 times
05 Thu Mar 2026 2226.40 2191.60 to 2239.80 0.87% 0.43 times
04 Wed Mar 2026 2207.20 2195.10 to 2235.00 -1.71% 0.94 times
02 Mon Mar 2026 2245.50 2161.00 to 2251.10 -0.09% 0.75 times
27 Fri Feb 2026 2247.60 2235.00 to 2275.00 -1.41% 1.09 times
26 Thu Feb 2026 2279.70 2145.90 to 2284.90 5.75% 3.8 times
25 Wed Feb 2026 2155.70 2052.80 to 2165.00 4.92% 1.1 times
24 Tue Feb 2026 2054.70 2029.40 to 2060.60 0.4% 0.3 times
23 Mon Feb 2026 2046.60 2012.30 to 2050.00 1.1% 0.3 times
20 Fri Feb 2026 2024.30 2014.90 to 2057.30 -0.75% 0.28 times
19 Thu Feb 2026 2039.50 2031.00 to 2088.40 -1.74% 1.02 times
18 Wed Feb 2026 2075.60 2048.00 to 2078.30 0.62% 0.29 times

Videos related to: MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

 

Back to top